06/18/09

TED KARKUS APPOINTED INTERIM CHIEF EXECUTIVE OFFICER OF THE QUIGLEY CORPORATION

06/17/09

COLD-EEZE® LOZENGES NOT AFFECTED BY FDA ADVISORY FOR ZICAM® INTRA-NASAL PRODUCTS

06/15/09

Ted Karkus and Karkus Slate of Directors Prevail in Federal Court, Seated as Directors of The Quigley Corporation

 

More +

In 2005, the world finally awoke to the possibility of a global influenza pandemic as the avian flu virus spread across Asia into Africa and Europe.  But avian flu was hardly the only health concern in the headlines: the continuing diabetes epidemic, the growing threat of nuclear terrorism, and additional warnings on common pain relievers also dominated.

Enter Quigley Pharma. With a growing pipeline, the Company is developing numerous compounds to address several major health issues facing the world today.

+ More

8.03.06

SEC Filing

2008

Download 2008 Annual Report

+ More